WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Linda GraisDirector2023-05-1510,000$2.45
$24.50kBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.16%6,943,654$15.97MInsider
Peter A. Thompson14.16%6,943,654$15.97MInsider
Orbimed Advisors LLC14.16%6,943,654$15.97MInstitution
Ecor1 Capital LLC10.53%5,162,154$11.87MInsider
Adams Street Partners LLC6.94%3,402,422$7.83MInsider
Terry P. Gould6.94%3,402,422$7.83MInsider
Adams Street Partners LLC6.68%3,275,616$7.53MInstitution
Samlyn Capital LLC5.09%2,496,259$5.74MInstitution
Richard A. Md Miller3.11%1,525,833$3.51MInsider
Holdings A. Novo2.83%1,389,498$3.20MInsider

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS39.12%60.38%Net Buying
VIGL44.03%55.97%Net Buying
BCAB56.19%33.81%Net BuyingNet Buying
ANIX13.87%85.06%Net Buying
CRBP6.06%93.94%Net BuyingNet Buying

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 39.12% institutional shareholders, 60.38% Corvus Pharmaceuticals insiders, and 0.50% retail investors. Orbimed Advisors LLC is the largest individual Corvus Pharmaceuticals shareholder, owning 6.94M shares representing 14.16% of the company. Orbimed Advisors LLC's Corvus Pharmaceuticals shares are currently valued at $16.04M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.